Category: Clinical Trials - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Psilocybin for Depression Study Approved and Funded by German Government

Psilocybin for Depression Study Approved and Funded by German Government

Post published:November 19, 2020
Post category:Clinical Trials News

Read more about the article Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Post published:November 14, 2020
Post category:Clinical Trials Research

Read more about the article Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

Post published:October 22, 2020
Post category:Clinical Trials News

Read more about the article First Psilocybin for Depression Clinical Trial Launched in Sweden

First Psilocybin for Depression Clinical Trial Launched in Sweden

Post published:October 16, 2020
Post category:Clinical Trials News

Read more about the article Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

Post published:August 19, 2020
Post category:Clinical Trials News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.